AVITA Medical (RCEL) Cash from Operations (2019 - 2025)
AVITA Medical (RCEL) posted Cash from Operations of 5438000.0 for Q4 2025, down 4.2% on a QoQ basis from 5219000.0 in Q3 2025, and up 32.71% year-over-year from 4097769.3 in Q4 2024.
AVITA Medical (RCEL) Cash from Operations (2019 - 2025) Analysis & Trends
AVITA Medical's Cash from Operations history runs 7 years deep, the most recent figure standing at 5438000.0 for Q4 2025.
- Quarterly Cash from Operations rose 32.71% year-over-year to 5438000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 31195000.0 (up 36.26% YoY) and the FY2025 annual result came in at 31195000.0, up 36.26% from the prior year.
- Cash from Operations was 5438000.0 for Q4 2025 at AVITA Medical, down from 5219000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 6845000.0 in Q4 2022 and bottomed at 20864000.0 in Q1 2024.
- A 5-year average of 9110352.94 and a median of 9101000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations tumbled 258.7% — and 2025, when it jumped 50.59%.
- AVITA Medical's Cash from Operations stood at 13129000.0 in 2021, then jumped by 152.14% to 6845000.0 in 2022, then tumbled by 258.7% to 10863000.0 in 2023, then climbed by 25.61% to 8081000.0 in 2024, then soared by 32.71% to 5438000.0 in 2025.
- Business Quant data shows RCEL's Cash from Operations at 5438000.0 in Q4 2025, 5219000.0 in Q3 2025, and 10229000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | -5.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.44 Mn |
| Dec 31, 2025 | -5.44 Mn |
| Sep 30, 2025 | -5.22 Mn |
| Sep 30, 2025 | -5.22 Mn |
| Jun 30, 2025 | -10.23 Mn |
| Jun 30, 2025 | -10.23 Mn |
| Mar 31, 2025 | -10.31 Mn |
| Mar 31, 2025 | -10.31 Mn |
| Dec 31, 2024 | -8.08 Mn |
| Dec 31, 2024 | -8.08 Mn |
| Sep 30, 2024 | -7.21 Mn |
| Sep 30, 2024 | -7.21 Mn |
| Jun 30, 2024 | -12.78 Mn |
| Jun 30, 2024 | -12.78 Mn |
| Mar 31, 2024 | -20.86 Mn |
| Mar 31, 2024 | -20.86 Mn |
| Dec 31, 2023 | -10.86 Mn |
| Dec 31, 2023 | -10.86 Mn |
| Sep 30, 2023 | -8.97 Mn |
| Sep 30, 2023 | -8.97 Mn |